BACKGROUND: Our aim was to examine the health resource utilization and cost of care associated with heart failure (HF) and diabetes mellitus (DM) for elderly Medicare enrollees. METHODS AND RESULTS: A retrospective case-control design was used to identify 4 groups of elderly patients with HF and DM (n = 498), HF only (n = 1089), DM only (n = 971), and no-HF and no-DM (n = 5438) using an administrative database of a large urban academic health care system. Demographic, diagnostic, health resource utilization, and cost (reimbursement) data were obtained from the Medicare claims database for the years 2000 and 2001. Disease states were identified by ICD-9 codes. Costs and health resource utilization were compared across the groups. The mean total costs were highest for the group with HF and DM ($32,676), and second highest for the HF only group ($22,230). In multivariable models that adjusted for potentially influential covariates, the group with HF and DM had a 3-fold increase in total cost compared with the group without DM and HF (relative total cost = 4.51, 95% confidence interval 3.82-5.31). CONCLUSIONS: The presence of DM has a substantial influence on the costs for managing older patients with HF. An integrated approach to management may be needed. Copyright 2010 Elsevier Inc. All rights reserved.
BACKGROUND: Our aim was to examine the health resource utilization and cost of care associated with heart failure (HF) and diabetes mellitus (DM) for elderly Medicare enrollees. METHODS AND RESULTS: A retrospective case-control design was used to identify 4 groups of elderly patients with HF and DM (n = 498), HF only (n = 1089), DM only (n = 971), and no-HF and no-DM (n = 5438) using an administrative database of a large urban academic health care system. Demographic, diagnostic, health resource utilization, and cost (reimbursement) data were obtained from the Medicare claims database for the years 2000 and 2001. Disease states were identified by ICD-9 codes. Costs and health resource utilization were compared across the groups. The mean total costs were highest for the group with HF and DM ($32,676), and second highest for the HF only group ($22,230). In multivariable models that adjusted for potentially influential covariates, the group with HF and DM had a 3-fold increase in total cost compared with the group without DM and HF (relative total cost = 4.51, 95% confidence interval 3.82-5.31). CONCLUSIONS: The presence of DM has a substantial influence on the costs for managing older patients with HF. An integrated approach to management may be needed. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: Molly G Ware; Carol M Flavell; Eldrin F Lewis; Anju Nohria; Lynne Warner-Stevenson; Michael M Givertz Journal: Congest Heart Fail Date: 2006 May-Jun
Authors: Elise M Pelletier; Paula J Smith; Kristina S Boye; Derek A Misurski; Sandra L Tunis; Michael E Minshall Journal: Appl Health Econ Health Policy Date: 2008 Impact factor: 2.561
Authors: Mark J Russo; Annetine C Gelijns; Lynne W Stevenson; Bhaven Sampat; Keith D Aaronson; Dale G Renlund; Deborah D Ascheim; Kimberly N Hong; Mehmet C Oz; Alan J Moskowitz; Eric A Rose; Leslie W Miller Journal: J Card Fail Date: 2008-07-21 Impact factor: 5.712
Authors: Paul L Hebert; Jane E Sisk; Jason J Wang; Leah Tuzzio; Jodi M Casabianca; Mark R Chassin; Carol Horowitz; Mary Ann McLaughlin Journal: Ann Intern Med Date: 2008-10-21 Impact factor: 25.391
Authors: Marita G Titler; Gwenneth A Jensen; Joanne McCloskey Dochterman; Xian-Jin Xie; Mary Kanak; David Reed; Leah L Shever Journal: Health Serv Res Date: 2008-04 Impact factor: 3.402
Authors: I García-Nogueras; I Aranda-Reneo; L M Peña-Longobardo; J Oliva-Moreno; P Abizanda Journal: J Nutr Health Aging Date: 2017 Impact factor: 4.075
Authors: Gina Nicholson; Shravanthi R Gandra; Ronald J Halbert; Akshara Richhariya; Robert J Nordyke Journal: Clinicoecon Outcomes Res Date: 2016-09-21